Literature DB >> 28127963

Long-term results of maxillary distraction osteogenesis in nongrowing cleft: 5-years experience using internal device.

D Hirjak, J P Reyneke, J Janec, M Beno, I Kupcova.   

Abstract

Patients with cleft lip and palate (CLP) related deformities frequently have maxillary hypoplasia in all dimensions. These patients usually present with class III malocclusions, retruded midfaces and narrow hard palates. The skeletal problems can be treated by means of Le Fort I maxillary procedures. Surgical and orthodontic correction of severe maxillary hypoplasia, as often seen in CLP patients, has however proved to be challenging. The magnitude of the advancement is often hampered and the post operative stability significantly affected by palatal soft tissue scarring. The slow distraction of bone and the histogenic abilities of distraction osteogenesis (DO) have made it an atractive alternative treatment option for the management of maxillary hypoplasia in these patients. This paper presents the treatment results of 15 nongrowing CLP patients with severe maxillary hypoplasia treated by means of intra oral distraction. The mean anterior distraction of the maxillas was 12.7 mm (9-15.0 mm). The long-term cephalometric and clinical evaluation after a minimum of 60 months (mean follow-up 71 months) proved to be stable. The treatment results revealed, that distraction osteogenesis in nongrowing CLP patients with severe maxillary hypoplasia proved to be a predictable and stable option (Tab. 2, Fig. 3, Ref. 26).

Entities:  

Keywords:  cleft lip and palate (CLP); distraction osteogenesis (DO); internal device maxillary hypoplasia.

Mesh:

Year:  2016        PMID: 28127963     DOI: 10.4149/BLL_2016_134

Source DB:  PubMed          Journal:  Bratisl Lek Listy        ISSN: 0006-9248            Impact factor:   1.278


  1 in total

1.  Temporomandibular joint dislocation in patients with cleft lip and palate after maxillary distraction osteogenesis: Three case reports.

Authors:  Binqing Wang; Junya Zhai; Yilue Zheng; Haizhou Tong; Yang Lü; Zhewei Chen; Ningbei Yin; Tao Song
Journal:  Medicine (Baltimore)       Date:  2021-02-12       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.